欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号PT/H/2133/001
药品名称Letrozole 2.5mg Film Coated Tablets
活性成分
    • Letrozole 2.5 mg
剂型Film-coated tablet
上市许可持有人FRESENIUS KABI ONCOLOGY PLC LION COURT FARNHAM ROAD BORDON HAMPSHIRE GU35 0NF UNITED KINGDOM
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
      Letrozole 2.5mg Film Coated Tablets
    • Netherlands (NL)
      Letrozol Kabi 2,5 mg filmomhulde tabletten.
    • Italy (IT)
    • Czechia (CZ)
      Letrozol Kabi 2,5 mg
    • Romania (RO)
      Letrozol Kabi 2,5 mg comprimate filmate
    • Greece (GR)
    • Ireland (IE)
    • France (FR)
    • Slovenia (SI)
许可日期2011/04/20
最近更新日期2025/01/23
药物ATC编码
    • L02BG04 letrozole
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase